NeuralCipher Source record
The Influence of Gut Microbiome on Alpha-Synuclein Aggregation: Implications for Parkinson's Disease Pathogenesis.
DOI: 10.1007/s12035-026-05917-6PMID: 42154337
A bibliographic record traceable to Europe PMC.
715 articles found
“Parkinson alpha synuclein” Clear search
Open access
PRKN/parkin-mediated control of SNCA (synuclein alpha) and chaperone-mediated autophagy are defective in cellular, mice models and Parkinson disease-affected brains.
DOI: 10.1080/15548627.2026.2669458PMID: 42083315
A bibliographic record traceable to Europe PMC.
Open access
Molecular profiling of alpha-synuclein pathology and seeding activity in Parkinson's disease.
DOI: 10.1007/s00401-026-03026-1PMID: 42118167
A bibliographic record traceable to Europe PMC.
Source record
How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease.
DOI: 10.1002/ana.78250PMID: 42095573
A bibliographic record traceable to Europe PMC.
Source record
Beyond Amyloids: Neuroprotective Potential of Betanin and its Derivatives Against Alpha-Synuclein Aggregates and ROS Overload in Parkinson's Disease.
DOI: 10.1007/s12031-026-02534-9PMID: 42081152
A bibliographic record traceable to Europe PMC.
Source record
Targeting Alpha-Synuclein Aggregation With Chemical Chaperone IP-045: An Approach to Parkinson's Disease Therapy.
DOI: 10.1002/ddr.70288PMID: 42003184
A bibliographic record traceable to Europe PMC.
Open access
Selective vulnerability of monoaminergic neurons and network spread of alpha-synuclein jointly explain pathology progression in Parkinson's disease models.
DOI: 10.1016/j.nbd.2026.107403PMID: 42055257
A bibliographic record traceable to Europe PMC.
Open access
Single-molecule detection methods to study alpha-synuclein aggregation in postmortem Parkinson's disease brains.
DOI: 10.1016/j.crmeth.2026.101418PMID: 42030949
A bibliographic record traceable to Europe PMC.
Source record
Rab27b: A Modulator of Lysosomal Function and Alpha-Synuclein Clearance in Parkinson's Disease.
DOI: 10.1523/jneurosci.0917-25.2026PMID: 42020315
A bibliographic record traceable to Europe PMC.
Open access
Clinical Progression in Alpha-Synuclein Positive LRRK2-PD and Sporadic Parkinson's Disease: A Longitudinal Analysis.
DOI: 10.1002/mdc3.70640PMID: 42003081
A bibliographic record traceable to Europe PMC.
Open access
Synergistic Effects of Multi-Kinase Inhibition on <i>LRRK2</i>-G2019S and Alpha-Synuclein Pathologies in Models of Parkinson's Disease.
DOI: 10.3390/biomedicines14040927PMID: 42072468
A bibliographic record traceable to Europe PMC.
Open access
Shared Epitope-Positive <i>HLA</i> Alleles Protect Against Alpha-Synuclein Pathology in a Model of Parkinson Disease.
DOI: 10.1212/nxi.0000000000200580PMID: 41996655
A bibliographic record traceable to Europe PMC.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.